APC/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
  • 30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
    C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103115 25 µg 79€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103116 100 µg 157€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Naito H, et al. 2020. Nature Protocols. 15(3):1066-1081. PubMed
  3. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  4. Heindl S, et al. 2021. J Exp Med. 218:. PubMed
  5. Stefkovich M, et al. 2021. Mol Metab. 54:101357. PubMed
  6. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  7. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  8. De Vries LCS, et al. 2021. J Crohns Colitis. 15:617. PubMed
  9. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
  10. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  11. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  12. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  13. Ren D, et al. 2022. STAR Protoc. 3:101217. PubMed
  14. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  15. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  16. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  17. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  18. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  19. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  20. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  21. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  22. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  23. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  24. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  25. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  26. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  27. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  28. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  29. Urban SK, et al. 2020. Liver Int. 40:3103. PubMed
  30. Page N, et al. 2018. Immunity. 48:937. PubMed
  31. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  32. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  33. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  34. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  35. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  36. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  37. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  38. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  39. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  40. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  41. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  42. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  43. Baram T, et al. 2021. Cells. 10:. PubMed
  44. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  45. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  46. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  47. Adrover JM, et al. 2022. JCI Insight. 7:. PubMed
  48. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  49. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  50. Kawashima N, et al. 2022. Nat Commun. 13:1624. PubMed
  51. Zhu S, et al. 2022. Front Pharmacol. 13:996635. PubMed
  52. Palacios LM, et al. 2022. Biology (Basel). 11:. PubMed
  53. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  54. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  55. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  56. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  57. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  58. Pluchino N, et al. 2020. J Cell Mol Med. 24:2464. PubMed
  59. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  60. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  61. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  62. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  63. Biswas S, et al. 2021. Nature. 591:464. PubMed
  64. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  65. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  66. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  67. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  68. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  69. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  70. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  71. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  72. Mantia-Smaldone G, et al. 2014. Gynecol Oncol. 133:584. PubMed
  73. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  74. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
  75. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  76. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  77. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  78. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  79. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  80. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  81. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  82. Armaka M, et al. 2022. Genome Med. 14:78. PubMed
  83. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  84. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  85. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  86. Wiley CD, et al. 2019. JCI Insight. 4:e130056. PubMed
  87. Krasteva G, et al. 2011. Proc Natl Acad Sci U S A. 108:9478. PubMed
  88. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  89. Marangoni F, et al. 2021. Cell. . PubMed
  90. Wang LT, et al. 2021. STAR Protocols. 2(1):100337. PubMed
  91. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  92. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  93. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  94. Schönfeld M, et al. 2021. Alcohol Clin Exp Res. 45:1980. PubMed
  95. Bhattacherjee A, et al. 2021. Mol Neurodegener. 16:19. PubMed
  96. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  97. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  98. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  99. Ning F, et al. 2019. J Exp Med. 216:1396. PubMed
  100. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  101. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  102. Evans R, et al. 2019. Cell Rep. 27:1967. PubMed
  103. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  104. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  105. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  106. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  107. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  108. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  109. Donlan AN, et al. 2020. Anaerobe. 66:102275. PubMed
  110. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  111. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  112. Commerford CD et al. 2018. Cell reports. . PubMed
  113. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  114. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  115. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  116. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  117. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  118. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  119. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  120. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  121. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  122. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  123. Zhang X, et al. 2020. Elife. 9:00. PubMed
  124. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  125. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  126. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  127. Gao H, et al. 2021. Cells. 10:. PubMed
  128. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  129. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  130. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  131. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  132. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  133. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  134. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  135. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  136. Veremeyko T, et al. 2012. J Vis Exp. 65: 4097. PubMed
  137. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  138. Oladiran O, et al. 2021. J Neuroinflammation. 77:18. PubMed
  139. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  140. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  141. Ali M, et al. 2022. JCI Insight. 7:. PubMed
  142. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  143. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  144. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  145. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  146. Ayaub E,et al. 2017. Sci Rep.. 10.1038/s41598-017-13511-z. PubMed
  147. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  148. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  149. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  150. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  151. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  152. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  153. Martina M, et al. 2014. J Vis Exp. 87: 51192. PubMed
  154. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  155. Neuhöfer P, et al. 2021. Nature. 597:715. PubMed
  156. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  157. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  158. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  159. Selvaraj UM, et al. 2021. Brain Behav Immun. 95:502. PubMed
  160. Ying T, et al. 2021. Am J Physiol Endocrinol Metab. 320:E1148. PubMed
  161. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  162. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  163. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  164. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  165. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  166. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  167. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  168. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  169. Hoeksema M, et al. 2015. J Immunol. 194:3909. PubMed
  170. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  171. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  172. Cardenas JJ, et al. 2020. Methods Enzymol. 415:631. PubMed
  173. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  174. Yang Y, et al. 2022. Elife. 11:. PubMed
  175. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  176. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  177. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  178. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  179. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  180. Gierut J, et al. 2015. Stem Cell Res. 15: 165-171. PubMed
  181. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  182. Haka A, et al. 2012. PLoS One. 7:e44823. PubMed
  183. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  184. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  185. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  186. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  187. Clement CC, et al. 2021. Nat Commun. 12:4447. PubMed
  188. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  189. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  190. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  191. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  192. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  193. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  194. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  195. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  196. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  197. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  198. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  199. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  200. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  201. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  202. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  203. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  204. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  205. Michaelis KA, et al. 2019. Brain Behav Immun. 82:338. PubMed
  206. Ou YC, et al. 2020. ACS Nano. 1.035416667. PubMed
  207. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  208. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  209. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  210. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  211. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  212. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  213. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  214. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  215. Wang X, et al. 2022. Front Immunol. 13:864984. PubMed
  216. Galani IE, et al. 2022. STAR Protoc. 3:101151. PubMed
  217. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  218. Draper D, et al. 2012. J Immunol. 188:5327. PubMed
  219. Hohsfield LA, et al. 2020. J Neuroinflammation. 0.902083333. PubMed
  220. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  221. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  222. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  223. Selvaraj UM et al. 2018. Endocrinology. 159(11):3848-3859 . PubMed
  224. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  225. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  226. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  227. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  228. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  229. Lu Z, et al. 2021. J Clin Invest. 131:. PubMed
  230. Luo M, et al. 2021. J Immunol. 207:1683. PubMed
  231. Wakabayashi T et al. 2018. Cell stem cell. 22(3):384-397 . PubMed
  232. Kaiser T, et al. 2019. Eneuro. 6. PubMed
  233. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  234. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  235. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  236. Klein S, et al. 2016. J Cell Sci. 129: 2573 - 2585. PubMed
  237. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  238. Pedicone C, et al. 2022. iScience. 25:104170. PubMed
  239. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  240. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  241. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  242. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  243. Milich LM, et al. 2021. J Exp Med. 218:. PubMed
  244. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  245. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  246. Starikova E, et al. 2021. Front Pharmacol. 12:667572. PubMed
  247. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  248. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  249. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  250. Jiang P, et al. 2018. Nat Med. 24:1550. PubMed
  251. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  252. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  253. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
  254. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  255. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  256. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  257. Morein D, et al. 2021. Cells. 10: . PubMed
  258. Yan C, et al. 2022. NPJ Precis Oncol. 6:6. PubMed
  259. Phansalkar R, et al. 2021. Elife. 10:. PubMed
  260. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  261. Armaka M, et al. 2018. Nat Commun. 9:618. PubMed
  262. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  263. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  264. Martin A, et al. 2018. Oncotarget. 9:28364. PubMed
  265. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  266. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  267. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  268. Gago-Lopez N, et al. 2019. EMBO Mol Med. 11:e10697. PubMed
  269. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  270. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  271. Liu SS, et al. 2021. Immunity. :. PubMed
  272. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  273. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  274. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  275. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  276. Seeling M, et al. 2013. Proc Natl Acad Sci U S A. 110:10729. PubMed
  277. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  278. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  279. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  280. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  281. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  282. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  283. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  284. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  285. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  286. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  287. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  288. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  289. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  290. Lux A, et al. 2014. Cell Rep. 10:236. PubMed
  291. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  292. Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
  293. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  294. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  295. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  296. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  297. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  298. De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed
  299. Sibler E, et al. 2021. Cells. 10:. PubMed
  300. Oladiran O, et al. 2021. Front Immunol. 12:720733. PubMed
  301. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  302. Sebastian A, et al. 2021. Cells. 10:. PubMed
  303. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  304. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  305. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  306. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  307. Forte E, et al. 2020. Cell Rep. 30:3149. PubMed
  308. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  309. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  310. Parent AV, et al. 2021. Cell Reports. 36(7):109538. PubMed
  311. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  312. Ma Y, et al. 2021. Developmental Cell. 56(4):478-493.e11. PubMed
  313. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  314. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  315. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
  316. Lee S, et al. 2021. Autophagy. Online ahead of print. PubMed
  317. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  318. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  319. Sun D, et al. 2020. PLoS Pathog. 16:e1008361. PubMed
  320. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  321. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  322. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  323. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
RRID
AB_312980 (BioLegend Cat. No. 103115)
AB_312981 (BioLegend Cat. No. 103116)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC, IHC-F, CyTOF®, IP, CMCD, IHC, WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC, SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC, ICC, IHC, 3D IHC, SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC, SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F, FC, 3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC, SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC, CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC, CyTOF®, IP, CMCD, IHC, WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Go To Top Version: 3    Revision Date: 01.30.2019

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD45

  • Biotin anti-mouse CD45

  • FITC anti-mouse CD45

  • PE anti-mouse CD45

  • PE/Cyanine5 anti-mouse CD45

  • Purified anti-mouse CD45

  • PE/Cyanine7 anti-mouse CD45

  • APC/Cyanine7 anti-mouse CD45

  • Alexa Fluor® 488 anti-mouse CD45

  • Alexa Fluor® 647 anti-mouse CD45

  • Pacific Blue™ anti-mouse CD45

  • Alexa Fluor® 700 anti-mouse CD45

  • PerCP/Cyanine5.5 anti-mouse CD45

  • PerCP anti-mouse CD45

  • Alexa Fluor® 594 anti-mouse CD45

  • Brilliant Violet 421™ anti-mouse CD45

  • Brilliant Violet 570™ anti-mouse CD45

  • Brilliant Violet 510™ anti-mouse CD45

  • Brilliant Violet 605™ anti-mouse CD45

  • Purified anti-mouse CD45 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD45

  • Brilliant Violet 711™ anti-mouse CD45

  • Brilliant Violet 785™ anti-mouse CD45

  • Brilliant Violet 650™ anti-mouse CD45

  • APC/Fire™ 750 anti-mouse CD45

  • Brilliant Violet 750™ anti-mouse CD45

  • TotalSeq™-A0096 anti-mouse CD45

  • TotalSeq™-B0096 anti-mouse CD45

  • Ultra-LEAF™ Purified anti-mouse CD45

  • Spark Blue™ 550 anti-mouse CD45

  • Spark NIR™ 685 anti-mouse CD45

  • TotalSeq™-C0096 anti-mouse CD45

  • Spark YG™ 570 anti-mouse CD45

  • PE/Fire™ 640 anti-mouse CD45

  • APC/Fire™ 810 anti-mouse CD45

  • PE/Fire™ 700 anti-mouse CD45

  • Spark Violet™ 538 anti-mouse CD45

  • Spark YG™ 593 anti-mouse CD45

  • Spark Blue™ 574 anti-mouse CD45 Antibody

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account